monia and septic shock from CA-MR-SA in Japan.
A 16-month-old, previously healthy boy was admitted to the hospital for fever and shortness of breath on August 30, 2006. He had had coldlike symptoms for 14 days and fever for the 2 previous days. On examination, hordeolum of the right eyelid and cyanosis were observed; the patient's blood pressure was 106/ (undetectable) mm Hg, tachycardia 185 beats/ min, tachypnea 72 breaths/min, and temperature 39.8°C. He had bilateral coarse breath sounds, and bronchovesicular breath sounds over the right lung. Chest radiography indicated lobar consolidation and pleural effusion on the right side. Laboratory analysis showed leukocytopenia, thrombocytopenia, elevated C-reactive protein level, and hypoxemia.
Intravenous administration of sulbactam/ampicillin and cefotaxime, and oxygen inhalation was started. Oxygen saturation did not improve, and laboratory values of disseminated intravascular coagulation (DIC) were observed: platelet count 121 K/mm 3 , fi brinogen level 528 mg/dL, fi brin degradation products 37.7 μg/mL, prothrombin time 1.86 international normalized ratio, and D-dimer 37.7 μg/mL. The condition was considered septic shock, and consequently the boy was transferred to the pediatric intensive care unit, where he required intubation and mechanical ventilation.
Sulbactam/ampicillin was switched to meropenem, and cefotaxime was continued. On day 2 after admission, chest radiography showed bilateral consolidation. On day 3, blood culture yielded MRSA, and cefotaxime was changed to vancomycin. Meropenem therapy was continued to cover possible mixed bacterial infection. Immunoglobulin therapy and DIC syndrome treatment (nafamostat mesilate, ulinastatin, freeze-dried concentrated human antithrombin III) were also started. On day 4, computed tomographic examination detected pneumothorax and athelectasis. Because laboratory data confi rmed the presence of only MRSA, meropenem was changed to fl omoxef (which belongs to the oxacephem family of β-lactam antimicrobial agents) on the expectation that a possible synergistic effect of fl omoxef and vancomycin might occur. No major changes occurred on days 5 and 6. On day 7, in addition to bilateral infi ltrates on chest radiography, the oxygen index was 65 (partial pressure of arterial oxygen/ fraction of inspired oxygen), and the patient was considered to have acute respiratory distress syndrome. A percutaneous cardiopulmonary support system (a portable heart-lung machine that provides temporary circulatory support) was used, but in spite of treatment, there was no improvement, and the child died on day 10 after admission (September 8). An autopsy was not performed.
Molecular characterization of MRSA isolated from the blood was performed as described previously (8, 9) . Isolated MRSA (strain NN32) was positive for PVL, belonging to ST30:spa19:staphylococcal cassette chromosome mec (SCCmec)IVa, and was resistant to only β-lactam antimicrobial agents (Table) .
To date, all cases of PVL-positive CA-MRSA infections offi cially reported in Japan were caused by strains belonging to ST30 (9) . All these strains can be classifi ed into 2 types on the basis of spa type (Table) , for example, ST30:spa19:SCCmecIVc. This type includes strain NN1, isolated from an 11-month-old patient with bullous impetigo (8); strain NN12, isolated from a 17-year-old patient with cutaneous abscess/osteomyelitis (8); strain NN31, isolated from an 18-year-old patient with pelvic abscesses (9); and strain EB00449, isolated from a 27-year-old patient with cutaneous abscesses (9) . Another type is ST765 (single locus variant of ST30):spa43:SCCmecIVx. This type includes strain DB00319, isolated from a 61-year-old hospital inpatient (9) .
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The molecular characteristics of strain NN32 were similar to those of strain NN1, except for SCCmecIV subtypes (Table) . Moreover, pulsed-fi eld gel electrophoresis patterns (data not shown) and the PVL gene sequences of the 2 strains (NN32 and NN1) were identical (Table) .
This case of CA-MRSA ST30 infection in a child represents a progression from common cold-like symptoms (occurring outside the infl uenza season) to fatal pneumonia, despite intensive therapy, including the administration of sensitive antimicrobial agents. CA-MRSA ST30 contains several genes that mediate adhesion (e.g., cna and bbp) and toxin genes (PVL and egc, which encode for at least 5 superantigens, including staphylococcal enterotoxin G, I, M, N, and O). The gene cluster egc is associated with septic shock (10) . Further studies are needed to clarify the pathogenesis of community-acquired pneumonia caused by CA-MRSA. 
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